LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.92 | 21.74 | 1817 | 6070 | 0.2993 | 0.7241 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.92 | 21.74 | 1975 | 6070 | 0.3254 | 0.7419 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.92 | 21.74 | 11 | 6070 | 0.0018 | -0.0804 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 93.92 | 21.74 | 2295 | 6070 | 0.3781 | 0.7744 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.24 | 21.74 | 426 | 183 | 2.3206 | 1.6291 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.24 | 21.74 | 2 | 183 | 0.0109 | -0.5394 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.24 | 21.74 | 733 | 183 | 3.9930 | 2.1361 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.24 | 21.74 | 580 | 317 | 1.8251 | 1.3364 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.24 | 21.74 | 827 | 317 | 2.6024 | 1.5608 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.21 | 21.74 | 661 | 392 | 1.6862 | 1.2668 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.21 | 21.74 | 885 | 392 | 2.2577 | 1.4310 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.19 | 21.74 | 2 | 439 | 0.0045 | -0.4230 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.19 | 21.74 | 708 | 439 | 1.6096 | 1.2319 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.19 | 21.74 | 2 | 439 | 0.0045 | -0.4230 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.19 | 21.74 | 919 | 439 | 2.0893 | 1.3702 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.16 | 21.74 | 730 | 463 | 1.5745 | 1.2166 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.16 | 21.74 | 932 | 463 | 2.0102 | 1.3427 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | E13 |